Allo BMT Using Matched Related/Unrelated Donors With FluBu and HiCY
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Myelodysplastic Syndrome
Related studies linked through entity extraction aliases.
A Phase 1 Dose Escalation Study of TAK-901 in Subjects With Advanced Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Thymoglobulin and Cyclosporine in Patients With Aplastic Anemia or Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE2
A Study of JNJ-30979754 (Decitabine) in Patients With Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE1
Safety Study of 5-Azacitidine and Standard Donor Lymphocyte Infusion (DLI) to Treat Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) Relapsing After Allogeneic Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
Bendamustine in Acute Leukemia and MDS
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Clofarabine Plus Low-Dose Cytarabine Induction and Decitabine Consolidation in Frontline Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS)
- Status
- COMPLETED
- Phase
- PHASE2
Busulfan Plus Cyclophosphamide vs Fludarabine as a Conditioning Regimen
- Status
- COMPLETED
- Phase
- PHASE3
High-dose Cytarabine/Mitoxantrone Followed by Autotransplantation for t-MDS/t-AML
- Status
- COMPLETED
- Phase
- PHASE2
Blood Samples to Evaluate Biomarkers of Donor Chimerism
- Status
- COMPLETED
- Phase
- N/A
Trial of Decitabine in Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE2
An Efficacy and Safety Study of Decitabine in Participants With Myelodysplastic Syndrome (MDS)
- Status
- COMPLETED
- Phase
- PHASE2
A Phase I Dose Escalation Study of Oral SB939 Administered Alone or With Azacitidine
- Status
- COMPLETED
- Phase
- PHASE1
Conditioning Regimen and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients With Hematologic Malignancies.
- Status
- COMPLETED
- Phase
- PHASE2
The Role of Erythropoietin in Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- N/A
Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
5-Azacytidine Prior to Allogeneic Stem Cell Transplant in High Risk Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE2
Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease
- Status
- COMPLETED
- Phase
- PHASE2
CASPALLO: Allodepleted T Cells Transduced With Inducible Caspase 9 Suicide Gene
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Reduced Intensity Total Body Irradiation + Thymoglobulin Followed by Allogeneic PBSCT
- Status
- COMPLETED
- Phase
- PHASE2